Share
872 Posts.
lightbulb Created with Sketch. 14
clock Created with Sketch.
16/12/22
20:32
Share
Originally posted by needle:
↑
There are aspects of this company, its drug, its share price....that I do believe are seen once in a lifetime (of investing). Melodramatic ? and maybe words of others even used from time to time, with their stock investment - but oh no, this is different. The previous post - beyond any doubt whatsoever highlights what the potential of PI3K and radiation. Only paxalisib - only paxalisib is in clinical studies in this combination. You know the published results so far - millions of cancer patients are prescribed radiation every day. ----------------------------------------- So what do you think - is the situation here unprecedented FOR A US$10 MILLION COMPANY ? or what. Also I can't be bothered to further explain - but there is a 50% chance in 9 months -the company will seek approval to market this drug paxalisib for GBM (first new drug for GBM in 15 years). At a likely gross annual sale of US$600m- profit US$300m means the drug would be worth US$3 BILLION for GBM. ----------------------------------------------------------------------------------------------- Still investing at 90 years of age - I don't think you will see this situation again.
Expand
if there was a real belief in the 50% chance as you say even in current conditions it should be easy for the company to raise through a white knight investor 20 to 50 mill at a 40 to 100 mill valuation. so either the company reps are completely incompetent in their duties, or you are way off with optimism!